# Extracorporeal Membrane Oxygenation (ECMO): Blood Cells

> **NCT02748668** · — · TERMINATED · sponsor: **Corewell Health West** · enrollment: 371 (actual)

## Conditions studied

- Extracorporeal Membrane Oxygenation

## Interventions

- **OTHER:** Blood specimen collection

## Key facts

- **NCT ID:** NCT02748668
- **Lead sponsor:** Corewell Health West
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2015-01-20
- **Primary completion:** 2023-08-23
- **Final completion:** 2023-08-23
- **Target enrollment:** 371 (ACTUAL)
- **Why stopped:** Study was not able to achieve primary objective and there is no intention to work towards its achievement
- **Last updated:** 2024-06-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02748668

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02748668, "Extracorporeal Membrane Oxygenation (ECMO): Blood Cells". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02748668. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*